Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Pancreas. 2013 Apr;42(3):494–501. doi: 10.1097/MPA.0b013e31826a8597

Figure 1. Distribution of biomarkers analyzed in the pancreatic juice of non-pancreatic non-healthy, chronic pancreatitis, and pancreatic cancer patients.

Figure 1

Distribution of pancreatic juice macrophage inhibitor cytokine-1 (MIC-1; A); neutrophil gelatinase–associated lipocalin (NGAL; B); and carbohydrate antigen 19-9 (CA19-9; C) of non-pancreatic non-healthy (NPNH) patients, chronic pancreatitis (CP) patients, and pancreatic cancer (PC) patients. NGAL and MIC-1 were measured by enzyme-linked immunosorbent assay (ELISA), while CA19-9 was measured by radioimmunoassay. MIC-1 and NGAL values are given in ng/mL, CA19-9 values are given in U/mL.